4//SEC Filing
Zuga Matt 4
Accession 0001576885-24-000010
CIK 0001576885other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:20 PM ET
Size
329.0 KB
Accession
0001576885-24-000010
Insider Transaction Report
Form 4
Zuga Matt
CFO & Chief Business Officer
Transactions
- Award
Employee Stock Option (right to buy)
2024-01-02+159,000→ 159,000 totalExercise: $4.23Exp: 2034-01-01→ Common Stock (159,000 underlying) - Award
Common Stock
2024-01-02+106,000→ 215,687 total
Footnotes (2)
- [F1]Represents a restricted stock unit ("RSU") award. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The RSUs will vest in three equal annual installments commencing one year after the grant date, subject to the Reporting Person's continuous service through each such vesting date.
- [F2]The shares subject to the option will vest in 48 equal monthly installments such that the option is fully vested on the fourth anniversary of the date of grant, subject to the Reporting Person's continuous service through each such vesting date.
Issuer
Acumen Pharmaceuticals, Inc.
CIK 0001576885
Entity typeother
Related Parties
1- filerCIK 0001790214
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:20 PM ET
- Size
- 329.0 KB